News & Analysis on Clinical Trial Services & Contract Research And Development
US raw materials supplier Originates has boosted its pharmaceutical bovine hide gelatin manufacturing capacity with the addition of two new ISO 9000/9001 certified, GMP-standard production facilities in South America.
Rising demand in China has led to Toray Fine Chemicals (TFC) establishing a joint venture to produce dimethylsulfoxide (DMSO), a reaction solvent in pharma production.
Outsourcing-Pharma presents its latest round up of movements in the pharmaceutical outsourcing sector, including appointments at WuXi, OctoPlus and Catalent.
UK group Chiltern International has opened an office in Budapest Hungary, joining the growing number of CRO players to set up in the CEE.
Mylan has followed Teva’s lead by partnering to develop follow-on biologics (FOB), with the Indian generic maker regarding Biocon as the “ideal partner” to help it enter the market.
Covance has doubled the capacity for large-scale, long-term stability and release programmes at its facility in Madison, Wisconsin, US.